REVUFORJ Trademark

Trademark Overview

On Thursday, January 19, 2023, a trademark application was filed for REVUFORJ with the United States Patent and Trademark Office. The USPTO has given the REVUFORJ trademark a serial number of 97979939. The federal status of this trademark filing is REGISTERED as of Tuesday, May 27, 2025. This trademark is owned by Syndax Pharmaceuticals, Inc.. The REVUFORJ trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cancer
revuforj

General Information

Serial Number97979939
Word MarkREVUFORJ
Filing DateThursday, January 19, 2023
Status700 - REGISTERED
Status DateTuesday, May 27, 2025
Registration Number7812206
Registration DateTuesday, May 27, 2025
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 28, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cancer

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, February 8, 2023
Primary Code005
First Use Anywhere DateFriday, November 15, 2024
First Use In Commerce DateFriday, November 15, 2024

Trademark Owner History

Party NameSyndax Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameSyndax Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451
Party NameSyndax Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressWaltham, MA 02451

Trademark Events

Event DateEvent Description
Tuesday, November 28, 2023PUBLISHED FOR OPPOSITION
Friday, July 12, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, January 23, 2023NEW APPLICATION ENTERED
Tuesday, October 17, 2023ASSIGNED TO EXAMINER
Friday, October 20, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, November 28, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, February 8, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 12, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, November 8, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 23, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, July 12, 2024SOU EXTENSION 1 FILED
Friday, July 12, 2024SOU EXTENSION 1 GRANTED
Tuesday, January 21, 2025SOU TEAS EXTENSION RECEIVED
Wednesday, January 22, 2025DIVISIONAL REQUEST RECEIVED
Wednesday, January 22, 2025TEAS STATEMENT OF USE RECEIVED
Wednesday, January 22, 2025TEAS REQUEST TO DIVIDE RECEIVED
Saturday, March 29, 2025CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, April 14, 2025STATEMENT OF USE PROCESSING COMPLETE
Tuesday, January 21, 2025SOU EXTENSION 2 FILED
Wednesday, January 22, 2025USE AMENDMENT FILED
Monday, April 14, 2025SOU EXTENSION 2 GRANTED
Monday, April 14, 2025DIVISIONAL PROCESSING COMPLETE
Monday, May 5, 2025NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, May 21, 2025TEAS WITHDRAWAL OF ATTORNEY RECEIVED
Tuesday, April 15, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, May 5, 2025ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, May 19, 2025TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, May 19, 2025ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, May 19, 2025TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, May 21, 2025WITHDRAWAL OF ATTORNEY GRANTED
Tuesday, May 27, 2025REGISTERED-PRINCIPAL REGISTER
Tuesday, May 27, 2025NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

revuforj cancer treatment preparations pharmaceutical